Comparison of Functional Outcomes and Associated Complications in Patients Who Underwent Total Hip Arthroplasty for Femoral Neck Fracture in Relation to Their Underlying Medical Comorbidities

키워드

참고문헌 (36)

1. Bozic KJ, "The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization", J Bone Joint Surg Am, 87, pp.1746~1751 (2005)
2. Ridgeway S, "Infection of the surgical site after arthroplasty of the hip", J Bone Joint Surg Br, 87, pp.844~850 (2005)
3. Bozic KJ, "Risk factors for periprosthetic joint infection following primary total hip arthroplasty : a case control study", J Arthroplasty, 29, pp.154~156 (2014)
4. Poultsides LA, "In-hospital surgical site infections after primary hip and knee arthroplasty : incidence and risk factors", J Arthroplasty, 28, pp.385~389 (2013)
5. Dale H, "Increasing risk of prosthetic joint infection after total hip arthroplasty", Acta Orthop, 83, pp.449~458 (2012)
6. Everhart JS, "Medical comorbidities are independent preoperative risk factors for surgical infection after total joint arthroplasty", Clin Orthop Relat Res, 471, pp.3112~3119 (2013)
7. Namba RS, "Risk factors associated with surgical site infection in 30, 491 primary total hip replacements", J Bone Joint Surg Br, 94, pp.1330~1338 (2012)
8. Kannus P, "Epidemiology of hip fractures", Bone, 18, pp.57S~63S (1996)[DOI]
9. Avery PP, "Total hip replacement and hemiarthroplasty in mobile, independent patients with a displaced intracapsular fracture of the femoral neck : a seven-to ten-year follow-up report of a prospective randomised controlled trial", J Bone Joint Surg Br, 93, pp.1045~1048 (2011)
10. Lai K, "Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties", J Arthroplasty, 22, pp.651~656 (2007)
11. Pulido L, "Periprosthetic joint infection : the incidence, timing, and predisposing factors", Clin Orthop Relat Res, 466, pp.1710~1715 (2008)
12. van Vugt AB, "Osteosynthesis versus endoprosthesis in the treatment of unstable intracapsular hip fractures in the elderly. A randomised clinical trial", Arch Orthop Trauma Surg, 113, pp.39~45 (1993)
13. Bozic KJ, "Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients", J Bone Joint Surg Am, 94, pp.794~800 (2012)
14. Song KH, "Differences in the risk factors for surgical site infection between total hip arthroplasty and total knee arthroplasty in the Korean Nosocomial Infections Surveillance System(KONIS)", Infect Control Hosp Epidemiol, 33, pp.1086~1093 (2012)
15. Paxton EW, "Are there modifiable risk factors for hospital readmission after total hip arthroplasty in a US healthcare system?", Clin Orthop Relat Res, 473, pp.3446~3455 (2015)
16. Parvizi J, "Proceedings of the international consensus meeting on periprosthetic joint infection. Foreword", J Orthop Res, 32(Suppl 1), pp.S2~S3 (2014)
17. Golden SH, "Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes", Diabetes Care, 22, pp.1408~1414 (1999)
18. Moghissi ES, "American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control", Endocr Pract, 15, pp.353~369 (2009)
19. Horan TC, "CDC definitions of nosocomial surgical site infections, 1992 : a modification of CDC definitions of surgical wound infections", Infect Control Hosp Epidemiol, 13, pp.606~608 (1992)
20. Ousey K, "Surgical wound dehiscence: improving prevention and outcomes", Wounds UK, 1, pp.48~ (2018)
21. Travis EC, "Clinical outcomes of total hip arthroplasty for fractured neck of femur in patients over 75 years", J Arthroplasty, 30, pp.230~234 (2015)
22. Berry DJ, "Effect of femoral head diameter and operative approach on risk of dislocation after primary total hip arthroplasty", J Bone Joint Surg Am, 87, pp.2456~2463 (2005)
23. van Kasteren ME, "Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty : timely administration is the most important factor", Clin Infect Dis, 44, pp.921~927 (2007)
24. Joshi N, "Infections in patients with diabetes mellitus", N Engl J Med, 16, pp.1906~1912 (1999)
25. Eibl N, "Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study", Clin Immunol, 103(3 Pt 1), pp.249~259 (2002)
26. Pozzilli P, "The immune response to influenza vaccination in diabetic patients", Diabetologia, 29, pp.850~854 (1986)
27. Marchant MH Jr, "The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty", J Bone Joint Surg Am, 91, pp.1621~1629 (2009)
28. Maradit Kremers H, "Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty", J Arthroplasty, 30, pp.439~443 (2015)
29. Jain NB, "Comorbidities increase complication rates in patients having arthroplasty", Clin Orthop Relat Res, (435), pp.232~238 (2005)
30. England SP, "Total knee arthroplasty in diabetes mellitus", Clin Orthop Relat Res, (260), pp.130~134 (1990)
31. Forrest G, "Factors affecting length of stay and need for rehabilitation after hip and knee arthroplasty", J Arthroplasty, 13, pp.186~190 (1998)
32. Serna F, "Total knee arthroplasty in diabetic patients. Comparison to a matched control group", J Arthroplasty, 9, pp.375~379 (1994)
33. Yang K, "Total knee arthroplasty in diabetic patients : a study of 109 consecutive cases", J Arthroplasty, 16, pp.102~106 (2001)
34. 전영수, "Clinical Implication of Diabetes Mellitus in Primary Total Hip Arthroplasty", Hip and Pelvis, 26(3), pp.136~142 (2014), 대한고관절학회[DOI]
35. Perka C, "Influencing factors on perioperative morbidity in knee arthroplasty", Clin Orthop Relat Res, (378), pp.183~191 (2000)
36. Freedman DS, "Trends and correlates of class 3 obesity in the United States from 1990 through 2000", JAMA, 288, pp.1758~1761 (2002)

관련 논문AI추천